Exosome mediated crosstalk in gastrointestinal cancers progression: special focus on Integrin β3 as a cargo
Cancer Letters · 2026-08 · 654 · 218617
DOI: 10.1016/j.canlet.2026.218617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-08. Verfasst von Ganji Purnachandra Nagaraju und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, 92093, USA. Hauptthemen laut MEDLINE: Exosomes, Gastrointestinal Neoplasms, Integrin beta3. Die Arbeit nennt 180 Literaturangaben. Gefördert von: NCI NIH HHS, University of California, San Diego, National Institutes of Health.
Abstract (Originalsprache)
Intercellular communication within the tumor microenvironment (TME) is highly active in gastrointestinal (GI) cancers, and exosomes have an important function in tumor development, progression, metastasis, angiogenesis, and drug resistance. Exosomes secreted by tumor cells actively remodel their local environment by delivering oncogenic proteins, genetic material, and integrins, contributing to processes such as invasion, immune escape, and metastatic niche formation. Cancer-associated fibroblasts (CAFs) are a main source of exosomes in the stroma, and their presence boosts tumor progression by orchestrating changes in the extracellular matrix composition, metabolism, and epithelial to mesenchymal transition. Similarly, exosomes produced by endothelial cells facilitate angiogenesis and increase vascular permeability, providing a mechanism for tumor spread. One of the key factors recently discovered in exosomes is the integrin β3, which plays a major role in organotropic metastasis, cell adhesion, migration, and activation of signaling pathways in GI cancers. In this review, the biological roles of exosomes isolated from tumors, CAFs, and endothelial cells have been highlighted, especially with reference to the functional significance of integrin β3 in GI cancers. This review also provides insight into the application of integrin β3 in exosomes as a biomarker for early detection, diagnosis, and treatment. The knowledge gained through exosome-based signaling could lead to new approaches for interfering with TME-associated tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, 92093, USA.
- Division of Medical Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, 92093, USA. Electronic address: belrayes@health.ucsd.edu.
Förderung
- NCI NIH HHS
- University of California, San Diego
- National Institutes of Health
Zitieren
APA
Nagaraju, G. P., Sarvesh, S., & El-Rayes, B. F. (2026). Exosome mediated crosstalk in gastrointestinal cancers progression: special focus on Integrin β3 as a cargo. Cancer Letters, 654, 218617. https://doi.org/10.1016/j.canlet.2026.218617
Vancouver
Nagaraju GP, Sarvesh S, El-Rayes BF. Exosome mediated crosstalk in gastrointestinal cancers progression: special focus on Integrin β3 as a cargo. Cancer Letters. 2026;654:218617. doi:10.1016/j.canlet.2026.218617
BibTeX
@article{Nagaraju2026,
author = {Nagaraju, Ganji Purnachandra and Sarvesh, Sujith and El-Rayes, Bassel F},
title = {Exosome mediated crosstalk in gastrointestinal cancers progression: special focus on Integrin β3 as a cargo},
journal = {Cancer Letters},
year = {2026},
volume = {654},
pages = {218617},
doi = {10.1016/j.canlet.2026.218617}
}
EUVIMED